drugset / Trial / NCT01012232

Local Anesthetic in Total Knee Arthroplasty (TKA): Volume Versus Concentration

NCT01012232 ↗

Phase 4 Completed 48 enrolled Lundbeck Foundation
RandomizedCrossoverQuadruple-blindTreatment

Summary

In a randomized, double-blind, cross-over trial, 48 patients scheduled for total knee arthroplasty with placement of an intracapsular catheter will be randomized to receive bolus injection of ropivacaine in high volume/low concentration (20 ml, 5 mg/mL) or low volume/high concentration (10 mL, 10 mg/mL) 6 and 24 hours postoperatively, and pain will be assessed at rest and with mobilization for 2 hours after injections.

Timeline

Start
2009-06
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 5 mg/ml Other
Subject Ropivacaine Other / unclassified 10 ml Other
Subject Ropivacaine Other / unclassified 10 mg/ml Other
Subject Ropivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.